FDA Approved: ABACAVIR, LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin's supplemental application for the fixed-dose combination Abacavir/lamivudine/zidovudine for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Abacavir, Lamivudine and Zidovudine (abacavir, lamivudine and zidovudine)

Snippet

SUPPL AP for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE (ABACAVIR , LAMIVUDINE AND ZIDOVUDINE)